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Pediocin PA-1 is a bacteriocin which is produced by Pediococcus acidilactici PAC1.0. We demonstrate that
pediocin PA-1 kills sensitive Pediococcus cells and acts on the cytoplasmic membrane. In contrast to its lack of
impact on immune cells, pediocin PA-1 dissipates the transmembrane electrical potential and inhibits amino
acid transport in sensitive cells. Pediocin interferes with the uptake of amino acids by cytoplasmic membrane
vesicles derived from sensitive cells, while it is less effective with membranes derived from immune cells. In
liposomes fused with membrane vesicles derived from both sensitive and immune cells, pediocin PA-1 elicits an
efflux of small ions and, at higher concentrations, an efflux of molecules having molecular weights of up to
9,400. Our data suggest that pediocin PA-1 functions in a voltage-independent manner but requires a specific
protein in the target membrane.
Some lactic acid bacteria produce antimicrobial sub-
stances called bacteriocins (24). Several bacteriocins have
been isolated and purified, but in only a few cases has the
mode of action of these compounds been determined (26).
Nisin (5, 14, 27, 40), lactostrepcin 5 (50), and lactococcin A
(46) all act on the cytoplasmic membrane of target cells.
Although poorly understood, the molecular mechanisms by
which these bacteriocins function differ. Many lactic acid
bacteria are used in food fermentation, and because of their
bacteriocin production, these strains are used as natural food
preservatives. Nisin is the only bacteriocin which is com-
monly used as a purified substance for food preservation
(38).
The genus Pediococcus comprises a large group of lactic
acid bacteria that are used commercially in meat (44) and
vegetable (35) fermentations. Pediococcus strains that pro-
duce bacteriocins are good candidates for food processing
and at the same time function in the preservation of pro-
cessed and fresh food (1, 32, 33). Purified pediocin has been
shown to be a good food preservative (49). Recently, it has
been suggested that Pediococcus strains might also be used
as silage inoculants (13).
In some of the bacteriocin-producing Pediococcus species
the genes determining bacteriocin production have been
localized on plasmids (8, 18, 19, 22, 32, 39). In Pediococcus
acidilactici PAC1.O, a gene cluster which includes the struc-
tural pediocin gene and genes for putative determinants of
the pediocin secretion and immunity mechanisms was local-
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ized on a 9.0-kbp plasmid. These genes have been cloned
and sequenced (32). Pediocin PA-1 has been purified to
homogeneity, and its primary structure has been determined
by Edman degradation (20). Pediocin PA-1 is synthesized as
a 62-amino-acid precursor and is cleaved behind two glycine
residues at a conserved cleavage (processing) site found in
several bacteriocins (30, 32). Mature pediocin PA-1 is a
highly hydrophobic, positively charged peptide consisting of
44 amino acids (20). The protein contains two disulfide bonds
(20). Pediocin PA-1 inhibits the growth of various bacteria,
including Listeria monocytogenes (20, 31, 37), which fre-
quently causes food-borne listeriosis (42, 48).
In this paper we describe the mode of action of pediocin
PA-1. We found that pediocin PA-1 acts on the cytoplasmic
membrane of target cells by forming voltage-independent
pores which cause an efflux of important cellular metabo-
lites.
MATERIALS AND METHODS
Bacterial strains and media. P. acidilactici PAC1.0 (18)
and Pediococcus pentosaceus PPE1.2 (17) were grown in
MRS broth or on MRS agar (Difco Laboratories, Detroit,
Mich.) at 30°C without aeration. For maintenance of the
pediocin plasmids, the cells were grown in the presence of 5
,ug of erythromycin per ml.
Determination of pediocin activity and production level.
Pediocin production in a sample was determined as de-
scribed previously (20); 1 arbitrary unit (AU) of pediocin
PA-1 activity was defined as the maximum dilution of a
pediocin-containing sample that caused a clearly visible zone
of inhibition in a sensitive P. pentosaceus PPE1.2 test
culture overlay.
Purification of pediocin PA-1 and pediocin-like bacteriocins.
Pediocin PA-1 was purified from the supernatant of P.
acidilactici PAC1.0 after overnight growth in CGB broth at
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30°C without aeration (2). The bacteriocin was concentrated
from the supernatant by ethanol precipitation and was puri-
fied by preparative isoelectric focusing on a Rotofor cell
(Bio-Rad Laboratories, Richmond, Calif.) according to the
instructions of the supplier. Sakacin P and sakacin A (cur-
vacin A) were isolated and purified as described elsewhere
(30, 45).
Measurement of A*. The transmembrane electrical poten-
tial (A+i) in intact cells was determined with an electrode
specific for the lipophilic cation tetraphenylphosphonium as
described previously (43).
Transport assays. Amino acid transport by Pediococcus
cells was analyzed as described previously for Lactococcus
lactis (46, 47). 1-14C-labeled 2-a-aminoisobutyric acid (AIB)
(59 mCi/mmol) and L-[U-14C]glutamate (285 mCi/mmol)
were used at final concentrations of 8.5 and 1.75 ,uM,
respectively. Uptake of L-[U-14C]leucine by membrane ves-
icles was analyzed in the presence of an imposed proton
motive force or by measuring counterflow as described
previously (46).
Isolation of lipids and preparation of CF-containing lipo-
somes. P. pentosaceus lipids were extracted (9) and washed
with acetone-ether as described previously (23). Unilamellar
liposomes with an average diameter of 100 nm were prepared
by the method of Goessens et al. (16). Lipids dissolved in
chloroform-methanol (9:1, vol/vol) were thoroughly dried
under a vacuum for 1 h. Traces of solvent were removed
under a stream of N2. The dry lipid was suspended (6 mg/ml)
in a buffer containing 50 mM carboxyfluorescein (CF) and 50
mM K-(2-[N-morpholino]ethanesulfonic acid) (K-MES) (pH
6.0). The lipid suspension was dispersed by ultrasonic irra-
diation with a bath-sonicator (Sonicor; Sonicor Instruments,
New York, N.Y.). Liposomes were obtained by five cycles
of freezing in liquid nitrogen and thawing in water at room
temperature and were subsequently extruded through 0.4-,
0.2-, and 0.1-,um-pore-size polycarbonate filters (Nuclepore
Co., Pleasanton, Calif.) (two times each) by using an extru-
sion device (Lipex Biomembranes, Vancouver, British Co-
lumbia, Canada). Nonencapsulated CF was removed from
the liposomes by gel filtration on Sephadex G-75 in 50 mM
K-MES. The liposomes were stored on ice until they were
used.
Preparation of membrane vesicles and fusion with lipo-
somes. Membrane vesicles of pediocin-sensitive and immune
P. pentosaceus cells were prepared by using the procedure
described by Driessen (9). The membrane vesicles (1 mg of
protein) were mixed with liposomes composed of P. pen-
tosaceus lipids (13.6 p,mol of phospholipid) in 50 mM
K-MES buffer (pH 6.0) and fused by freezing, thawing, and
sonication as described previously (11). Loading of the
hybrid membranes with CF was accomplished by adding CF
(50 mM) to the thawed hybrid membranes before sonication.
Hybrid membranes were collected by centrifugation for 1 h
at 280,000 x gm. at 4°C, were washed twice with 50 mM
K-MES (pH 6.0) to remove nonencapsulated CF, and finally
were resuspended in 100 ,ul of the same buffer.
Fluorescence measurements. Fluorescence measurements
were determined with a Perkin-Elmer model LS 50 spectro-
fluorimeter equipped with a thermostat and a continuous
stirring device. The efflux of CF from liposomes or hybrid
membranes was measured as described previously (15). At
an intraliposomal CF concentration of 50 mM, the fluores-
cence of CF is almost completely self-quenched. Release of
CF results in a relief of self-quenching which is recorded as
an increase in CF fluorescence with an excitation wave-
length of 430 nm (at which the inner-filter effect is negligible
[16]) and an emission wavelength of 520 nm. The excitation
and emission slit widths were 2.5 and 5.0 nm, respectively.
The experiments were performed at a constant temperature
of 25°C. Liposomes (70 ,ug of lipid per ml) or hybrid
membranes (50 ,ug of protein per ml) were suspended in
K-MES buffer (pH 6.0) and treated with pediocin PA-1 or the
same volume of solvent (i.e., 20% [vol/vol] ethanol). Com-
plete relief of self-quenching was obtained by adding 0.2%
(vol/vol) Triton X-100.
Efflux of high-molecular-mass fluorescein 5-isothiocy-
anate (FITC)-labeled dextrans (4.4 and 9.4 kDa) was mea-
sured as described previously (15). The FITC-labeled dex-
trans were trapped in fused membranes by adding these
components to thawed membranes before sonication. The
membranes were collected by centrifugation for 1 h at 28,000
x gm. at 4°C and were washed twice with 50 mM K-MES
buffer (pH 6.0) to remove nonencapsulated dextrans. The
membranes containing FITC-labeled dextrans were sus-
pended in 50 mM K-MES buffer (pH 6.0), and the efflux of
the dextrans was determined by monitoring the quenching of
fluorescein fluorescence by anti-fluorescein rabbit immuno-
globulin G (Molecular Probes, Inc., Eugene, Oreg.). Com-
plete release of the encapsulated dextran was obtained by
adding 0.2% (vol/vol) Triton X-100. The excitation and
emission wavelengths were 490 and 515 nm, respectively.
Slit widths of 10.0 nm were used both for excitation and
emission.
Tryptophan fluorescence emission spectra were deter-
mined with an SLM-AMINCO model 4800C spectrofluorom-
eter (SLM Instruments, Inc., Urbana, Ill.) from 290 to 400
nm by using an excitation wavelength of 280 nm. Slit widths
of 4 nm were used, and the spectra were corrected for
background fluorescence and averaged (n = 10) to reduce
the noise value.
Other analytic procedures. Protein concentrations in the
samples were determined by using the Micro BCA protein
assay reagent (Pierce, Rockford, Ill.). CF was purchased
from Eastman Kodak Co., Rochester, N.Y., and was puri-
fied as described previously (28) by using 50 mM K-MES
buffer (pH 6.5) as the eluent.
RESULTS
Pediocin PA-1 is bactericidal for sensitive cells. Pediocin
PA-1 inhibits the growth of various bacteria, including the
pathogen Listeria monocytogenes (34). To determine
whether pediocin PA-1 acted on a sensitive test culture of P.
pentosaceus PPE1.2 wild-type cells in a bacteriostatic, bac-
teriolytic, or bactericidal manner, the following experiment
was conducted. Overnight cultures of wild-type P. pentosa-
ceus PPE1.2 (pediocin sensitive) and a pediocin-insensitive
derivative carrying the immunity gene for pediocin PA-1
were diluted in fresh MRS broth containing pediocin PA-1 (5
x 102 AU/mg of protein). Pediocin PA-1 affected neither the
growth nor the number of CFU of the immune cells (Fig. 1).
In contrast, the number of CFU of the sensitive organism
decreased dramatically. The optical density of the cell cul-
ture remained constant. However, after longer periods of
time slight increases in both optical density and number of
CFU were observed, possibly as a result of inactivation of
the pediocin (3). These results indicate that pediocin PA-1 is
bactericidal for sensitive P. pentosaceus PPE1.2 cells.
Pediocin PA-1 dissipates theA* and elicits amino acid efflux
from sensitive cells. Since pediocin PA-1 is a small hydro-
phobic peptide (20) that resembles other bacteriocins, such
as lactococcin A (21), a possible target for its action is the
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FIG. 1. Effect of pediocin PA-1 on growth and viability of
sensitive and immune cells of P. pentosaceus PPE1.2. Symbols: 0
and 0, pediocin-sensitive P. pentosaceus PPE1.2 CFU and optical
density at 650 nm (OD650n,), respectively; * and Cl, pediocin-
insensitive P. pentosaceus PPE1.2 CFU and optical density at 650
nm, respectively. The amount of pediocin PA-1 used was 500
AU/mg of protein.
cytoplasmic membrane (46). Therefore, the effects of pedi-
ocin PA-1 on the A4 of sensitive and immune Pediococcus
cells were determined. A* (inside negative) was monitored
by using an electrode that measured the distribution of the
lipophilic cation tetraphenylphosphonium. Pediocin PA-1
(5 AU/mg of protein) caused immediate dissipation of the A*i
of intact sensitive cells (Fig. 2A), while it had only a minimal
effect on the A4 of the immune cells (Fig. 2B).
It is very likely that pediocin PA-1 eliminates the A* of
sensitive cells by changing the ion permeability of the
cytoplasmic membrane. To investigate whether pediocin
PA-1 elicited efflux of low-molecular-weight solutes, the
effect of pediocin PA-1 on amino acid transport was studied.
We studied the uptake of two amino acids which differ in
their mechanisms of uptake. AIB, a nonmetabolizable ana-
log of alanine, is accumulated in a Ap-dependent manner
(25), whereas L-glutamate is accumulated in a proton motive
force (Ap)-independent, most likely ATP-dependent manner
(36). Pediocin PA-1 (500 AU/mg of protein) caused the
immediate release of AIB accumulated by P. pentosaceus
PPE1.2 cells sensitive to this bacteriocin (Fig. 3A). In
contrast, the ionophore combination valinomycin plus ni-
gericin (1 ,uM each), which completely dissipates the Ap
(Fig. 2), caused a slow efflux of AIB. When P. pentosaceus
PPE1.2 cells were preincubated with pediocin PA-1 or with
valinomycin plus nigericin, no uptake of AIB occurred. In
contrast, when immune cells were used under the same
conditions, no release of AIB was observed when pediocin
PA-1 was added (data not shown). Because the inhibition of
AIB uptake might result from the dissipation of Ap by
pediocin in an indirect way, we examined the effect of
pediocin PA-1 on glutamate uptake. P. pentosaceus PPE1.2
cells were allowed to accumulate L-glutamate, and subse-
quently the cells were treated with pediocin PA-1, valino-
mycin plus nigericin, and all three substances. Accumulated
time (min)
FIG. 2. Effect of pediocin PA-1 on the A, of glucose-energized
sensitive (A) and immune (B) cells of P. pentosaceus PPE1.2. The
effect of the ionophore valinomycin (added at arrow 4) on the uptake
of the tetraphenylphosphonium ion (TPP') is indicated by the
dashed line. The arrows indicate the sequential times of addition of
cells (arrow 1), glucose (arrow 2), nigericin (arrow 3), and pediocin
PA-1 (50 AU/mg of protein) (arrow 4).
glutamate was not released by the ionophores valinomycin
and nigericin (Fig. 3B). However, pediocin PA-1 (500
AU/mg of protein) caused the immediate release of the
accumulated L-glutamate, both in the presence and in the
absence of valinomycin plus nigericin. These data suggest
that pediocin PA-1 forms pores in the cytoplasmic mem-
brane that allow the passage of small solutes, such as AIB
and glutamate. Moreover, pediocin PA-1 can function in the
absence of a Ap, as efflux of glutamate was also induced in
the absence of a Ap.
Pediocin PA-1 induces the release of low-molecular-weight
compounds from cytoplasmic membrane vesicles. To study
the pediocin PA-i-induced release of low-molecular-weight
compounds in more detail, we used cytoplasmic membrane
vesicles derived from sensitive and immune cells. Membrane
vesicles derived from sensitive (Fig. 4A) and immune (Fig.
4B) cells of P. pentosaceus PPE1.2 rapidly accumulated
leucine when a Ap was generated. The Ap was generated by
using valinomycin-mediated outwardly directed diffusion
gradients of potassium (A+, inside negative) and acetic acid
(chemical gradient of protons across the membrane [ApH],
inside alkaline). When membrane vesicles from pediocin-
sensitive cells were preincubated for 5 min in the presence of
pediocin PA-1 (1,000 AU/mg of protein), the ability to
accumulate leucine was completely lost (Fig. 4A). In con-
trast, membrane vesicles derived from immune cells accu-
mulated a significant level of leucine (Fig. 4B).
To determine whether pore formation underlies the
changes in membrane permeability caused by pediocin, we
studied the effect of pediocin PA-1 on leucine counterflow.
In these experiments membrane vesicles were loaded with 5
mM leucine and then diluted 50-fold in a medium containing
3.2 ,uM 14C-labeled leucine. Under these conditions, the
intravesicular pool of leucine exchanged rapidly with the
radiolabeled leucine, which accumulated transiently in re-
sponse to the outwardly directed leucine concentration
gradient (10, 12). The temporary accumulation of radioactive
solute does not require Ap. Preincubation of the membrane
VOL. 59, 1993
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FIG. 3. Effect of pediocin PA-1 on AIB (A) and glutamate (B) uptake in P. pentosaceus PPE1.2 cells. (A) Symbols: 0, uptake of AIB by
control cells (no additions); El, uptake of AIB in the presence of valinomycin plus nigericin (added at the time indicated by the arrow); A,
uptake ofAIB in the presence of pediocin PA-1 (added at the time indicated by the arrow); V, uptake ofAIB by cells which were preincubated
for 3 min with valinomycin plus nigericin or pediocin PA-1. Cells were energized with glucose. (B) Symbols: 0, uptake of L-glutamate by
control cells; U, uptake of L-glutamate by cells exposed to valinomycin and nigericin (added at the time indicated by arrow 1); A, uptake of
L-glutamate by cells exposed to pediocin PA-1 (500 AU/mg of protein) (added at the time indicated by arrow 2); 0, uptake of L-glutamate by
cells exposed to valinomycin plus nigericin and pediocin PA-1 (added at the times indicated by arrows 1 and 2, respectively).
vesicles of the sensitive cells with pediocin PA-1 (1,000
AU/mg of protein) completely destroyed leucine counterflow
activity. On the other hand, membrane vesicles of the
immune cells exhibited residual leucine counterflow activity
when they were incubated with pediocin PA-1 (data not
shown). These results suggest that pediocin PA-1 forms
pores in isolated cytoplasmic membrane vesicles and that
membrane vesicles derived from immune cells are more
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FIG. 4. Effect of pediocin PA-1 on Ap-driven leucine uptake by
cytoplasmic membrane vesicles derived from pediocin-sensitive (A)
and pediocin-insensitive (B) P. pentosaceus PPE1.2. Uptake of
leucine by membrane vesicles was determined without (O and El) or
with (- and *) pediocin PA-1. Membrane vesicles were preincu-
bated with pediocin PA-1 (1,000 AU/mg of protein) for 5 min.
To estimate the size of the pores formed by pediocin, we
studied the efflux from membrane vesicles of a number of
fluorescent molecules having various molecular weights.
The release of membrane vesicle-entrapped CF is a conve-
nient and sensitive technique which allowed us to perform an
assay of pore formation in real time. CF present at a high
concentration in the membrane vesicle lumina exhibited a
low level of fluorescence because of a high degree of
self-quenching. Release of CF was detected as relief of
self-quenching, as shown by an increase in CF fluorescence.
To load the membrane vesicles with CF, the vesicles were
fused with liposomes composed of phospholipids extracted
from P. pentosaceus cells. Liposomes loaded with CF were
completely resistant to pediocin, as no increase in CF
fluorescence was observed when pediocin (5,000 AU/mg of
protein) was added (Fig. 5). However, rapid release of CF
when pediocin PA-1 was added was observed in the hybrid
membranes prepared with membrane vesicles of both sensi-
tive and immune cells (Fig. 5).
A similar approach was used to analyze the pediocin
PA-1-induced efflux of 4.4-kDa FITC-labeled dextran (data
not shown) and 9.4-kDa FITC-labeled dextran (Fig. 6).
Release of FITC-labeled dextran from the hybrid mem-
branes prepared from sensitive membrane vesicles was
monitored with anti-fluorescein antibodies which, when
present on the outside, quenched the fluorescence of re-
leased FITC-labeled dextrans. When pediocin was present at
sufficiently high concentrations (2,000 AU/mg of protein), a
rapid release of the FITC-labeled dextrans was observed
(Fig. 6). At higher pediocin concentrations (5,000 AU/mg of
protein), the efflux of FITC-labeled dextrans was more
pronounced. These results suggest that pediocin PA-1 can
form large pores that allow membrane passage of high-
molecular-weight compounds. Moreover, these results sug-
gest that more pediocin is required to release compounds
APPL. ENvIRON. MICROBIOL.
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FIG. 5. Pediocin PA-1-induced efflux of CF from P. pentosaceus
membrane vesicles fused with liposomes. Liposomes prepared from
P. pentosaceus PPE1.2 phospholipids (line c) were fused with
membrane vesicles derived from pediocin-sensitive (line a) and
pediocin-insensitive (line b) cells in the presence of CF. Pediocin
PA-1 (5,000 AU/mg of protein) was added at time zero.
having higher molecular weights (Fig. 1 through 6). We
concluded that the cytoplasmic membrane is the target of
pediocin activity. However, sensitivity to pediocin requires
a factor(s) which is not present in liposomes prepared from
phospholipids derived from sensitive P. pentosaceus cells.
DTT inhibits pediocin PA-1 activity. The mature region of
pediocin PA-1 contains four cysteine residues which form
two disulfide bonds (20). The possible function of these
disulfide bonds in pediocin activity was studied by reducing
the peptide in the presence of dithiothreitol (DTT). DTI-
treated pediocin PA-1 had completely lost the ability to kill
sensitive cells when it was analyzed in a spot test (data not
shown).
Pediocin PA-1 contains two tryptophan residues at posi-
tions 19 and 33 and two tyrosine residues at positions 2 and
3. This allowed us to observe qualitative changes in the
tertiary structure of the molecule by examining tryptophan
fluorescence. When pediocin PA-1 was unfolded in 6 M
guanidine-HCl (Fig. 7), only minor changes in the trypto-
phan fluorescence spectrum were observed compared with
pediocin diluted in buffer. These data suggest that the
tryptophan (and tyrosine) residues of pediocin in buffer are
exposed to solvent, indicating that the molecule has an
unfolded or loose conformation. When pediocin PA-1 was
incubated in the presence of Eschenchia coli liposomes, the
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FIG. 6. Pediocin PA-1-induced efflux of FITC-labeled dextran
from P. pentosaceus membrane vesicles fused with liposomes.
Membrane vesicles from pediocin-sensitive cells were fused with
liposomes prepared from P. pentosaceus PPE1.2 phospholipids in
the presence of FITC-labeled dextran with an average molecular
mass of 9.4 kDa. The time of addition of pediocin PA-1 (line a, 5,000
AU/mg of protein; line b, 2,000 AU/mg of protein) is indicated by the
arrow. The accessibility of the FITC moiety to externally added
anti-fluorescein antibodies was monitored by measuring the de-
crease in fluorescein fluorescence.
with a blue shift of the emission maximum. These data
suggest that the tryptophan residues were transferred from a
polar environment to a nonpolar environment, possibly as a
result of membrane insertion or a lipid-induced conforma-
tional change of the molecule. Similar changes in the fluo-
rescence spectrum were obtained when pediocin PA-1 was
incubated in the presence of DTT, although the maximum
fluorescence was decreased because of inner-filter effects
caused by near-UV absorbance by DTT (data not shown).
Quenching of the tryptophan fluorescence by water-soluble
acrylamide was more efficient with the soluble pediocin (Fig.
7, inset) than with pediocin incubated in the presence of
lipids. To determine the depth of pediocin penetration into
the lipid bilayer, we prepared liposomes containing fatty acyl
chain doxyl-derivatized phosphatidylcholine analogs with
the doxyl moiety at various positions in the stearoyl fatty
acyl chain. The doxyl moiety is an efficient quencher of
tryptophan fluorescence provided that the tryptophan resi-
dues of pediocin are close to the doxyl group. The fluores-
cence levels were 0.83, 0.90, and 0.92 with the doxyl moiety
at positions 5, 10, and 16, respectively in the stearoyl fatty























FIG. 7. Tryptophan fluorescence of pediocin PA-1. Pediocin
PA-1 was incubated in 50mM K-MES buffer (pH 6.0) in the absence
(line a) or presence (line c) of liposomes composed of E. coli
phospholipids (40 ,ug) in a final volume of 110 pA. Line b is the
tryptophan fluorescence spectrum of pediocin unfolded in 6 M
guanidine-HCI-50 mM K-MES buffer (pH 6.0). (Inset) Stern-Volner
plot of the quenching of tryptophan fluorescence of pediocin PA-1
by acrylamide in the absence (0) and presence (O) of liposomes
composed of E. coli phospholipids. Fluorescence emission was
measured at 320 nm.
tryptophan residues of pediocin PA-1 are localized on the
surface when pediocin PA-1 is associated with liposomes.
The peptide may assume a more ordered structure upon
interaction with the membrane surface irrespective of the
reduction state of its disulfide bonds.
DISCUSSION
Pediocin PA-1 belongs to a group of bacteriocins produced
by Pediococcus spp. (7, 24, 29, 39). In this study we
examined the mode of action of pediocin PA-1. Our data
suggest that pediocin PA-1 kills sensitive cells by effecting
the release of metabolites by the formation of pores in the
target membranes.
Recently, the amino acid sequence of pediocin AcH was
described on the basis of both an amino acid sequence
determination and the sequence derived from the nucleotide
sequence of the gene (33). Pediocins AcH and PA-1 have
identical sequences. The protein is highly hydrophobic and
would be expected to interact with membranes (41). In
addition, several other bacteriocins exhibit high levels of
amino acid sequence homology with pediocin PA-1 (4, 30,
32). The results of our preliminary studies on the effect of the
bacteriocins sakacin A (curvacin A) and sakacin P (4, 45) on
glutamate release from P. pentosaceus PPE1.2 indicate that
these bacteriocins are also able to cause the release of
glutamate under conditions in which the Ap was dissipated
by the ionophores valinomycin and nigericin (6). These
bacteriocins may function like pediocin PA-1. Bhunia et al.
(3) showed that pediocin AcH binds with high efficiency to
the surfaces of cells in a nonspecific manner. On the basis of
the data presented by Bhunia et al. (3) and our results, we
propose the following working model for the mechanism of
action of pediocin PA-1 (AcH). Pediocin molecules first
adhere nonspecifically to the surfaces of target cells, and this
is followed by binding to a receptor-like component of the
cell membrane. The pediocins may then insert into the
membrane and aggregate into oligomeric structures. These
structures then form hydrophilic pores which allow the
release of ions and small molecules from the target cells;
ultimately, this leads to cell death, with or without lysis. Our
in vitro studies revealed that at high concentrations pediocin
functions in the absence of a proton motive force across the
membrane. In contrast to the lantibiotic nisin (15), imposi-
tion of a Ap did not affect the efficiency with which pediocin
caused release of fluorescent molecules from hybrid mem-
branes (6). We cannot exclude the possibility that in vivo Ap
contributes to the efficiency with which pediocin at a low
concentration acts on the target cell membranes.
Pediocin PA-1 acts in a bactericidal manner on sensitive P.
pentosaceus PPE1.2 cells. It may also exert a bacteriolytic
effect, depending on the species of the sensitive cells (3). The
activities of pediocin PA-1 in the different systems tested
strongly depend on the concentration used. Similar results
have been reported for lactococcin A (46), lactococcin B
(47), and pediocin JD (7). The latter bacteriocin may be
identical to pediocin PA-1 (AcH). Our data suggest that the
concentration of pediocin determines the size exclusion limit
of the pores. Only at higher concentrations was effective
release of the high-molecular-weight dextrans observed,
while lower concentrations of pediocin were sufficient to
dissipate the Ap. The lantibiotic nisin, however, does not
cause the release of dextrans from liposomes (15).
Reduction of the disulfide bonds in pediocin PA-1 resulted
in a complete loss of bacteriocin activity. It has been
reported that the cysteine residues present in sakacin A are
in a reduced state (4), while the cysteine residues in pediocin
PA-1 are in an oxidized state, forming disulfide bonds (20).
Two cysteine residues of pediocin PA-1, sakacin A (curvacin
A), and sakacin P are in the same positions (i.e., at position
9 or 10 and at position 14 or 15) in the primary structures of
the aligned sequences. The additional cysteine residues of
pediocin PA-1 at positions 24 and 44 are not present in
sakacin A and sakacin P. Since D1T does not inhibit the
antimicrobial activities of sakacin A and sakacin P (6), it
seems likely that the disulfide bond between the cysteine
residues at positions 24 and 44 is essential for pediocin PA-1
activity.
Pediocin PA-1 is ineffective against liposomes composed
of P. pentosaceus PPE1.2 phospholipids, but it does affect
hybrid membrane vesicles of this organism fused with lipo-
somes composed of both P. pentosaceus and E. coli phos-
pholipids (6). E. coli cells are not sensitive to pediocin PA-1.
These data suggest that there is a requirement for a protein
in the target membrane, as suggested for lactococcin A (46),
a bacteriocin produced by certain Lactococcus lactis strains,
rather than for a lipid component. Pediococcus cells which
synthesize the pediocin immunity protein are highly resistant
to pediocin PA-1 treatment. This property is partially pre-
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served in membrane vesicles derived from immune cells. A
similar phenomenon has been observed with lactococcin A
(46). On the other hand, the immunity phenotype appears to
be lost when these membrane vesicles are fused with lipo-
somes composed of Pediococcus phospholipids. The reason
for this observation is not known. Loss of the resistant
phenotype could be a result of inactivation or loss of the
immunity protein in the fused membranes. Proteinase K
treatment of membrane vesicles derived from both immune
and sensitive cells resulted in increased resistance of the
membrane vesicles of sensitive cells and decreased resis-
tance of membrane vesicles of immune cells (6). This implies
that there is a complicated mechanism of immunity in which
the immunity protein is not the only protein that participates.
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